IDEOM REVIEWED
PUBLICATIONS SINCE 2013


1. Gottlieb AB1, Armstrong AW. Psoriasis outcome measures: a report from the GRAPPA 2012 annual meeting. August 2013: J Rheumatol. 2013 Aug;40(8):1428-33. doi: 10.3899/jrheum.130456.  Read...


2. Gottlieb AB1, Armstrong AW1, Christensen R1, Garg A1, Duffin KC1, Boehncke WH1, Merola JF1, Gladman DD1, Mease PJ1, Swerlick RA1, Rosen CF1, Abernethy A1. The International Dermatology Outcome Measures initiative as applied to psoriatic disease outcomes: a report from the GRAPPA 2013 meetingJune 2014: J Rheumatol: 41(6):1227-9. doi: 10.3899/jrheum.140176  Read...


3. Varada, Sowmya & Kim, Noori & Abernethy, April & Armstrong, April & Callis-Duffin, Kristina & Garg, Amit & Gottlieb, Alice. (2014). IDEOM: International Dermatology Outcome Measures - Proceedings from the First Meeting. Psoriasis Forum. 20a. 66-72. 10.1177/247553031420a00207.  Read...


4. B Gottlieb, Alice & A Levin, Adriane & Armstrong, April & Abernethy, April & Duffin, Kristina & Bhushan, Reva & Garg, Amit & Merola, Joseph & Maccarone, Mara & Christensen, Robin. (2014). The International Dermatology Outcome Measures Group: Formation of patient-centered outcome measures in dermatology. Journal of the American Academy of Dermatology. 72. 10.1016/j.jaad.2014.11.002. Read...


5. James A. Solomon, M.D., Ph.D., Ryan Schuering, B.S. An Update on The IDEOM (International Dermatology Outcome Measures) Initiative to Restructure Current Psoriasis Outcome Assessment Measures to a Globally Uniform Set of Patient-Centric Outcome Measures for Use in Clinical Trials and Clinical Practice.Spring 2015: Psoriasis Forum, Vol. 21, No. 1. Read...


6. Greb JE, Merola J, Garg A, Latella J, Howard L, Acharya N, Gottlieb AB, Perez-Chada LM, Singh S, Callis-Duffin K, Garg A, Gottlieb AB, Latella J, Armstrong, AW, Merola JF. The Psoriatic Disease Payer Advisory Panel. J. Drugs in Dermatol. 15: 641-644, 2016. Read...


7. Greb JE, Merola J, Garg A, Latella J, Howard L, Acharya N, Gottlieb AB Elman SA, Merola JF, Armstrong AW, Callis Duffin K, Latealla J, Garg A, Gottlieb AB: The International Dermatology Outcome Measures (IDEOM) Initiative: A Review and Update. The Psoriatic Disease Payer Advisory Panel. J. Drugs in Dermatol. 15: 641-644, 2016. J.Drugs Dermatol. 16:119-124, 2017. Read...


8. Thorlacius L, Ingram JR, Garg A, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, Merola JF, Dellavalle R, Christensen R, Jemec GBE. Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes. BMJ Open 2017;7(2):e014733. Read...


9. Callis Duffin K, Merola JF, Christensen R, Latella J, Garg A, Gottlieb AB, Armstrong AW. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials:A Combined Delphi Consensus Survey from the International Dermatology Outcome Measures Initiative, JAMA Dermatology, Published online June 6, 2018. doi:10.1001/jamadermatol.2018.1165 Read...


10. Gottlieb AB, Merola JF, Chen r, Levi E, Callis Duffin K: Assessing clinical response and defining minimal disease activity in plaque psoriasis with the Physician Global Assessment and body surface area (PGA x BSA) composite tool: An analysis of apremilast phase 3 ESTEEM data. JAAD 77: 1178-1180, 2017. Read...


11. Gottlieb AB, Kirby B, Ryan C,Naegeli AN, Burge R, Bleakman AP, Anatchkova MD, Yosipovitch G. The development of a patient-reported measure for assessment of genital psoriasis symptoms: The genital psoriasis symptoms scales (GPSS). Dermatology and Therapy published online. https://doi.org/10.1007/s135555-017-0213-2, 2017 Read...


12. Gottlieb AB, Kirby B, Ryan C, Naegeli AN, Burge R, Bleakman AP, Anatchkova MD, Cather J: The development of the genital psoriasis sexual frequency questionnaire (GenPs-SFQ) to assess the impact of genital psoriasis on sexual health. Dermatology and Therapy, published online. https://doi.org/10.1007/s13555-017-0212-3, 2017 Read...


13. Thorlacius L, Ingram JR, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, Merola JF, Dellavalle R, Nielsen SM, Christensen R, Garg A and Jemec GBE, on behalf of the HIdradenitis SuppuraTiva cORe outcomes set International Collaboration (HISTORIC). A Core Domain Set For Hidradenitis Suppurativa Trial Outcomes: An International Delphi Process. Br J Dermatol. 2018 Apr 14. doi: 10.1111/bjd.16672 Read...


14. Thorlacius L, Garg A, Ingram JR, Villumsen B, Theut Riis P, Gottlieb AB, Merola JF, Dellavalle R, Ardon C, Baba R, Bechara FG, Cohen AD, Daham N, Davis M, Emtestam L, Fernandez-Penas P, Filippelli M, Gibbons A, Grant T, Guilbault S, Gulliver S, Harris C, Harvent C, Houston K, Kirby JS, Matusiak L, Mehdizadeh A, Mojica T, Okun M, Orgill D, Pallack L, Parks-Miller A, Prens E, Randel S, Rogers C, Rosen CF, Choon SE, van der Zee HH, Christensen R, Jemec GBE. Towards global consensus on core outcomes for Hidradenitis Suppurativa research: An update from the HISTORIC consensus meetings I and II. Br J Dermatol. 2018;178(3):715-721. Read...


15. Joseph F. Merola, David A. Amato, Kyoungah See, Russel Burge, Craig Mallinckrodt, Clement K Ojeh, Alice Gottlieb. Evaluation of sPGAxBSA as an outcome measure and treatment target for clinical practice. J. Invest. Dermatol. J Invest Dermatol. 2018 Mar 22. pii: S0022-202X(18)31741-X. doi: 10.1016/j.jid.2018.01.041. [Epub ahead of print] Read...


16. Salame N, Perez-Chada LM, Singh S, Duffin KC, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong AW. Are Your Patients Satisfied? A Systematic Review of Treatment Satisfaction Measures in Psoriasis. Dermatology, 2018 Aug 17:1-9. Read...


17. Salame N, Torres J, Sandhu J, Callis Duffin K, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong AW. Patient-Reported Outcome Measures for Pediatric Psoriasis: A Systematic Review and Critical Appraisal from International Dermatology Outcome Measures (IDEOM). Dermatology, in press Read...


18. Joseph F. Merola, David A. Amato, Kyoungah See, Russel Burge, Craig Mallinckrodt, Clement K Ojeh, Alice Gottlieb: Evaluation of sPGAxBSA as an outcome measure and treatment target for clinical practice. J. Invest. Dermatol. J Invest Dermatol. 2018 Mar 22. pii: S0022-202X(18)31741-X. doi: 10.1016/j.jid.2018.01.041. [Epub ahead of print]; 138:1955-1961. 2018. Read...


19. Perez-Chada LM, Cohen JM, Gottlieb AB, Duffin KC, Garg A, Latella J, Armstrong AW, Ogdie A, Merola JF. Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative. Archives of dermatological research. 2018 Aug 25:1-0. Read...


20. MD, PhD Alice Gottlieb, Nicole Salame, BA, April W. Armstrong, MD, MPH, Joseph F. Merola, MD, MMSc, Sylvia Parra, MD, Junko Takeshita, MD, PhD, MSCE, Suephy C. Chen, MD, MS, John Latella, BS, MS, Marta Van Beek, MD, MPH; Journal of the American Academy of Dermatology: "A Provider Global Assessment Quality Measure for Clinical Practice for Inflammatory Skin Disorders" Read...


21. "Achieving Consensus on Patient-Reported Outcome Measures in Clinical Practice for Inflammatory Skin Disorders On Behalf of International Dermatology Outcome Measures and the American Academy of Dermatology" - IN PRESS


22. Perez-Chada L*, Salame N*, Ford A, Callis Duffin K, Gottlieb A, Garg A, Latella J, Merola JF and Armstrong A. Investigator and Patient Global Assessment Measures in Psoriasis for Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative. American Journal of Clinical Dermatology (In press)*co-primary authors Read...

23. Lu JD, Hobbs MM, Huang WW, Ortega-Loayza AG, Alavi A. Indentification and evaluation of outcome measurement instruments in pyoderma gangrenosum: a systematic review. British Assoc of Dermatologists. 07 May 2020 published online. https://doi.org/10.1111/bjd.19027 Read...

24. Perez-Chada LM*, Singh S*, Callas Duffin K, Garg A, Gottlieb AB, Latella J, Armstrong AW, Merola JF. International Dermatology Outcome Measures (IDEOM) Group 2016 New York Meeting: Meeting Summary And Data From The Psoriasis Working Group. JDD. 2017 Aug;16(8):770-7. PMID 28809992. *co-primary authors Read...

25. Perez-Chada LM, Merola JF, Armstrong AW, Gottlieb AB. Report Of The Skin Research Workgroups From The GRAPPA 2018 Annual Meeting. The Journal of Rhuematology Suppl. 2019 Jun; 95:28-32. Read...

26. Perez-Chada, LM; Gottlieb AB; Cohen J; Callis Duffin K; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF. Measuring Psoriatic Arthritis Symptoms, A Core Domain In Psoriasis Clinical Trials. Journal of the American Academy of Dermatology. 2019 June 1 doi: 10.1016/j.jaad.2019.05.075. Read...

27. Perez-Chada LM, Taliercio VL, Gottlieb AB, Van Beek M, Duffin FC, Reeder M, Merola JF, Swerlick RA. Achieving Consensus On Patient-Reported Outcome Measures In Clinical Practice For Inflammatory Skin Disorders: On Behalf Of The International Dermatology Outcome Measures And The American Academy Of Dermatology. Journal of the American Academy of Dermatology. 2019 Sep13. doi: 10.1016/j.jaad.2019.09.008 Read...

28. Kornmehl H, Duffin KC, Salame N, Perez-Chada LM, Singh S, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong AW. Examination of Treatment Satisfaction Instruments in Psoriasis: 2017 Results from the Psoriasis Working Group of the International Dermatology Outcome Measures (IDEOM). Dermatology. 2020 Jan 28:1-7. doi: 10.1159/000501582 Read...

29. Perez-Chada LM; Balak, D; Cohen, J; Ogdie A; Merola JF; Gottlieb AB. Measurement properties of instruments assessing psoriatic arthritis symptoms for psoriasis clinical trials: a systematic literature review. Expert Review of Clinical Immunology. Expert Review in Clinical Immunology. 2020 Feb 8:1-7. doi: 10.1080/1744666X.2020.1724090 Read...

30. Perez-Chada LM, Merola JF, Armstrong AW, Gottlieb AB. Report of the Skin Research Workgroups from the GRAPPA 2019 Annual Meeting. J Rheumatol Suppl. 2020 Jun;96:36-40. doi: 10.3899/jrheum.200125. PMID: 32482766. Read...

31. Layton AM, Smith H, Thiboutot DM, Smith A, Whitehouse H, Ghumra W, Verma M, Tan J, Jones G, Gilliland K, Patel M, Otchere E, Eady EA. A Systematic Literature Review to Identify the Impacts of Acne and the Use of Questionnaires to Detect These Impacts. American Journal of Clinical Dermatology; DOI 10.1007/s40257-020-00564-6; In press.

32. Layton AM, Thiboutot DM, Tan J. Reviewing the Global Burden of acne: how could we improve care to reduce the burden? BJD-2020-1723.R2 ; Early view. Read...

33. Tan J, Miklas M. Developing a Core Outcome Set for Acne Clinical Trials: Towards standardization and harmonization. In Acne - Current Concepts and Management; in press, Nov 2020

34. van Zuuren EJ, Arents BWM, Miklas M, Schoones JW, Tan J. Patient reported satisfaction with acne treatment: a systematic review. In revision post-submission Br Jour Derm. Sep 2020. Read...

35. Tan J, Frey M, Thiboutot D, Layton A, Eady A. Identifying the impacts of acne: a Delphi survey of patients and clinicians. Journal of Cutaneous Medicine & Surgery. May/Jun 2020;24(3):259-266 Read...

36. AM Layton, DM Thiboutot, J Tan. Reviewing the Global Burden of acne: how could we improve care to reduce the burden? BJD-2020-1723.R2 ; Early view

37. Tan J, Miklas M. Developing a Core Outcome Set for Acne Clinical Trials: Towards standardization and harmonization. In Acne - Current Concepts and Management; in press Nov 2020

38. van Zuuren EJ, Arents BWM, Miklas M, Schoones JW, Tan J. Patient reported satisfaction with acne treatment: a systematic review. In revision post-submission Br Jour Derm. Sep 2020.

39. Tan J, Frey M, Thiboutot D, Layton A, Eady A. Identifying the impacts of acne: a Delphi survey of patients and clinicians. Journal of Cutaneous Medicine & Surgery. May/Jun 2020;24(3):259-266

40. Goldfarb N, Lowes MA, Butt M, King T, Alavi A, Kirby JS (2020). Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment. Br J Dermatol.

41. Goldfarb N, Ingram JR, Jemec GBE, Naik HB, Piguet V, Hyde MJ, Freese R, Lowes MA, Alavi A (2020). Hidradenitis Suppurativa Area and Severity Index (HASI): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa. Br J Dermatol 182(1):240

42. Kirby JS, Butt M, King T (2020). Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa. Br J Dermatol. 182(4):940

43. Kirby JS, Thorlacius L, Villumsen B, Ingram JR, Garg A, Christensen KB, Butt M, Esmann S, Tan J, Jemec GBE. The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials. Br J Dermatol. 2020 Aug;183(2):340-348.

44. Kirby JS, Hereford B, Thorlacius L, Villumsen B, Ingram JR, Garg A, Butt M, Esmann S, King T, Tan J, Jemec GBE. Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa. Br J Dermatol. 2020 Jun 29. doi: 10.1111/bjd.19344.

45. Sarfo A, Butt M, Kirby JS. Br J Dermatol. 2020;182(1):218.

46. Kirby JS, Moore B, Leiphart P, Shumaker C, et al. Br J Dermatol. 2020;182(1):24.

47. HS; BMJ Open 2017;7(2):e014733; Br J Dermatol. 2018;178(3):715-721; Br J Dermatol. 2018;179(3):642-650


IDEOM in the News


1. International group seeks to close gaps in psoriasis research - AAD Summer Academy Meeting News- 4.2.2014  Read...


2. Patients become full partners in inflammatory arthritis and psoriasis research - Dermatology News -7.15.2014; By: Ted Bosworth, Dermatology News Digital Network.  Read...


3. IDEOM featured in Dermatology Daily 8.3.2018.  Read...


4. Academy, IDEOM Reach Consensus On Provider-Assessed Global Disease Severity Metric For Inflammatory Dermatoses - Dermatology Advisor 11.21.2018; By: Shiela Jacobs Read...